Bionic tibia antibiotic bone cement spacer
Through the combination of bionic design and good biomechanical properties, the problems of fit and stability of traditional antibiotic cement placeholders are solved, and the effect of perfect axial with the femoral condyle surface and antibiotic release is achieved, reducing false Risk of peribody infection and muscle contracture.
Patent Information
- Application Number
- CN202323649164.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-29
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2033-12-29
AI Technical Summary
During the production and application of traditional antibiotic cement placeholders, there are problems such as insufficient joint surface fit, postoperative instability, and biomechanical properties that cannot meet the requirements, resulting in peripheral infections and muscle contractures.
A bionic tibial antibiotic bone cement placeholder was designed, using bionic-designed articular surfaces and intramedullary fixing shanks with good biomechanical properties, combined with antibiotic-containing bone cement materials, and manufactured with patients through 3D printing or mold casting technology. The tibia matches the placeholder body and the intramedullary fixing shank is made using cobalt chromium molybdenum alloy or titanium alloy material to increase support and anti-rotation structure for improved stability.
The placeholder perfectly matches the surface of the femoral condyle, improves biomechanical properties, expands the area of antibiotic release, effectively controls peripheral infections and avoids muscle contractures, and reduces the need for a second phase revision surgery.
Smart Images

Figure CN221998105U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of orthopedic medical instruments, in particular to a bionic tibial antibiotic bone cement placeholder. Background Art
[0002] As an important movement joint in the body, the knee joint plays a vital role in daily life. At the same time, the knee joint is also more susceptible to damage and infection. Artificial knee replacement is usually used as a treatment for damaged and severely infected knee joints. Periprosthetic infection after total knee replacement is a catastrophic complication that not only increases the patient's hospitalization time and surgical costs, but also leads to knee stiffness, decreased function, low patient satisfaction, and increased mortality. At present, the "gold standard" for treating periprosthetic infection is still a two-stage revision surgery. Especially for patients with chronic infection, the implantation of an antibiotic bone cement temporary spacer can eradicate microbial infection before the prosthesis is re-implanted to avoid muscle and tissue contracture.
[0003] At present, with the increase in the number of knee revision surgeries, the use of spacers is becoming more and more widespread. The traditional method of making spacers is to manually shape the structure with a shape and volume similar to the reconstruction part during surgery, which is somewhat different from the actual anatomical morphology or the morphology of the prosthesis. In addition, the precision of making spacers by surgeons with different experience is different, making it difficult to control the quality. Therefore, during the production and application of traditional spacers, there are defects such as insufficient joint surface fit, postoperative instability, and biomechanical properties that cannot meet the requirements. Summary of the invention
[0004] In order to solve the defects of traditional space holders such as insufficient joint surface fit, postoperative instability and biomechanical properties that cannot meet the requirements, the utility model provides a bionic tibial antibiotic bone cement space holder. The joint surface at the upper end of the space holder body adopts a bionic design, and the intramedullary support handle is made of materials with good biomechanical properties, which reduces the chances of periprosthetic infection after proximal tibial defect reconstruction and muscle and tissue contracture before secondary revision surgery, and solves the technical problems of traditional space holders such as insufficient fit, postoperative instability and unsatisfactory biomechanical properties.
[0005] The technical solution provided by the utility model is: a bionic tibial antibiotic bone cement placeholder, comprising a placeholder body and an intramedullary fixation handle, the placeholder body comprising an articular surface at the upper end and a soft tissue contact column at the lower end, the articular surface is a bionic design, matching the morphology of the proximal tibia joint surface of the patient; the intramedullary fixation handle comprises a support handle, a clamping platform and a connecting handle, the clamping platform is arranged between the support handle and the connecting handle; the support handle of the intramedullary fixation handle is arranged inside the placeholder body, and the lower end of the soft tissue contact column of the placeholder body is arranged on the clamping platform of the intramedullary fixation handle.
[0006] In the above technical solution, a raised anti-rotation groove is provided on the lower surface of the support handle, an exhaust hole is provided on the clamping table, and an anti-rotation groove is provided on the connecting handle.
[0007] In the above technical solution, the material of the spacer body is bone cement containing antibiotics; the material of the intramedullary fixation handle is one of cobalt-chromium-molybdenum alloy or titanium alloy, polyetheretherketone and polyetherketoneketone.
[0008] The beneficial effects of the utility model are as follows: compared with the existing technology, the joint surface of the proximal end, that is, the upper end of the spacer of the utility model is a bionic surface structure, which can be completely consistent with the surface of the femoral condyle, solving the problem of insufficient fit; secondly, the spacer adds an intramedullary support handle made of a material with good biomechanical properties, which effectively eliminates the unfavorable factor of the instability of the spacer caused by relying solely on bone cement as mechanical conduction; at the same time, the main part of the spacer is made of bone cement material containing antibiotics, which is in full contact with the soft tissue, expanding the release area and range of sensitive antibiotics. The utility model can locally provide antibiotics around the knee joint to achieve the effect of controlling the infection of the tissue around the prosthesis, and can effectively avoid muscle contracture around the knee joint, providing extremely effective help for the development of secondary surgery. BRIEF DESCRIPTION OF THE DRAWINGS
[0009] Figure 1 It is a schematic diagram of the structure of the utility model;
[0010] Figure 2 is a schematic diagram of the structure of the intramedullary fixation handle;
[0011] Figure 3 X-ray of the patient's left leg after implantation of the utility model;
[0012] Figure 4 This is an X-ray film of the patient's right leg after the utility model was implanted.
[0013] Among them: 1-1- placeholder body, 1-1- articular surface, 1-2- soft tissue contact column, 2- intramedullary fixation handle, 2-1- support handle, 2-1-1- anti-rotation belt groove, 2-2- clamping table, 2-2-1- exhaust hole, 2-3- connecting handle, 2-3-1, anti-rotation groove. DETAILED DESCRIPTION
[0014] like Figure 1 , Figure 2 As shown, a bionic tibial antibiotic bone cement placeholder comprises a placeholder body 1 and an intramedullary fixation handle 2, wherein a support handle 2-1 at the upper end of the intramedullary fixation handle 2 is inserted into the placeholder body 1;
[0015] First, the parameters of the affected limb are measured based on the patient's imaging data, and the geometric morphological parameters of the placeholder that fully matches the patient are reconstructed through reverse engineering. The bionic proximal tibia antibiotic bone cement placeholder mold is manufactured through 3D printing technology or mold casting technology. When making the mold of the placeholder body 1, the joint surface 1-1 at the upper end of the placeholder body 1 matches the morphology of the patient's proximal tibia joint surface, and the soft tissue contact column 1-2 at the lower end of the placeholder body is made into a smooth cylinder;
[0016] The intramedullary fixation handle 2 is made of titanium alloy material, a base 2-2 with a diameter of 21.5 mm is made in the middle of the intramedullary fixation handle 2, the part above the base 2-2 is a support handle 2-1 with a diameter of 6 mm; the part below the base 2-2 is a connecting handle 2-3 with a diameter of 7 mm; in order to facilitate the injection of bone cement, three exhaust holes 2-2-1 with a diameter of 3 mm are punched on the base 2-2; in order to prevent the intramedullary fixation handle 2 from rotating in the space holder body 1, four raised anti-rotation grooves 2-1-1 with a diameter of 8 mm are milled on the lower part of the supporting handle 2-1; in order to prevent the space holder from rotating in the patient's body, an anti-rotation groove 2-3-1 is milled on the connecting handle 2-3;
[0017] Bone cement containing antibiotics is injected into the mold, and the support handle 2-1 of the intramedullary fixation handle 2 is inserted into the bone cement before the bone cement solidifies. After the mold is opened, a bionic proximal tibia antibiotic bone cement placeholder is formed.
[0018] Specific implementation example: The patient is diagnosed with periprosthetic infection after total knee replacement, and it is decided to perform the implantation of an antibiotic bone cement placeholder after the prosthesis is removed. First, the tibial knee prosthesis is removed, and after thorough cleaning and debridement, the knee joint is straightened and flexed under traction to evaluate the bone defect and the flexion and extension gaps, and to determine the level of the knee joint line. The proximal tibia is flexed and pulled forward to fully expose the proximal tibia, and bone cement containing antibiotics is injected into the tibial medullary cavity. The assembled bionic proximal tibia antibiotic bone cement placeholder is implanted into the patient's tibial medullary cavity according to the anatomical structure. The articular surface 1-1 of the placeholder is matched with the proximal tibia articular surface of the patient according to the anatomical structure, and the bone cement enters the anti-rotation groove 2-3-1 on the connecting handle 2-3 of the intramedullary fixation handle 2 of the placeholder. The unsolidified bone cement and the bone cement of the bionic proximal tibia antibiotic bone cement placeholder are solidified into a whole, and the knee joint is moved to evaluate the matching degree of the placeholder and the joint stability. At this point, the bionic proximal tibia antibiotic bone cement placeholder is installed.
[0019] from Figure 3 , Figure 4The postoperative X-rays of the two patients shown in the figure show that the joint surface of the spacer 1-1 is consistent with the original joint surface anatomical morphology, and the bone defect is filled biomimetically. The intramedullary fixation handle 2 plays an effective role in support and intramedullary fixation. During the process of making the spacer, the exhaust hole 2-2-1 plays a role in gas discharge, effectively preventing the risk of reduced mechanical properties or even failure due to the presence of cavities inside the spacer. Three weeks after the operation, the patient can walk with a regular gait with the help of auxiliary equipment. Six weeks after the operation, the surrounding soft tissue scar heals, and biomimetic reconstruction is achieved on the basis of infection healing.
Claims
1. A bionic tibial antibiotic bone cement spacer, characterized in that: The invention comprises a placeholder body (1) and an intramedullary fixation handle (2), wherein the placeholder body (1) comprises an articular surface (1-1) at the upper end and a soft tissue contact column (1-2) at the lower end, wherein the articular surface (1-1) is of bionic design and matches the morphology of the proximal tibia articular surface of the patient; the intramedullary fixation handle (2) comprises a support handle (2-1), a clamping table (2-2) and a connecting handle (2-3), wherein the clamping table (2-2) is arranged between the support handle (2-1) and the connecting handle (2-3); the support handle (2-1) of the intramedullary fixation handle (2) is arranged inside the placeholder body (1), and the lower end of the soft tissue contact column (1-2) of the placeholder body (1) is arranged on the clamping table (2-2) of the intramedullary fixation handle (2).
2. A bionic tibial antibiotic bone cement spacer according to claim 1, characterized in that: A raised anti-rotation belt groove (2-1-1) is provided on the lower surface of the support handle (2-1), an exhaust hole (2-2-1) is provided on the clamping table (2-2), and an anti-rotation groove (2-3-1) is provided on the connecting handle (2-3).
3. A bionic tibial antibiotic bone cement spacer according to claim 1, characterized in that: The material of the spacer body (1) is bone cement containing antibiotics; the material of the intramedullary fixation handle (2) is one of cobalt-chromium-molybdenum alloy or titanium alloy, polyetheretherketone and polyetherketoneketone.
